Search / Trial NCT06222528

Reducing Stigma and Increasing Treatment Seeking Intentions Among Adolescents

Launched by NEW YORK STATE PSYCHIATRIC INSTITUTE · Jan 16, 2024

Trial Information

Current as of October 04, 2024

Completed

Keywords

Description

In a randomized control trial (RCT) with pre-, post-intervention, and 2 and 4 week follow-up assessments, the investigators aim to test the efficacy of brief social contact video interventions, varying protagonist race/ethnicity, as compared to video control in reducing depression related stigma and increasing treatment-seeking intentions and behavior among adolescents ages 14-18 recruited via Cloudresearch, a crowdsourcing platform. The control condition will include a video that will provide information about depression and how to seek help but does not include a personal story. The tailo...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Ages 14-18
  • * English speaking
  • * US Residents
  • Exclusion Criteria:
  • * Age less than 14 or greater than 18
  • * Non-English speaking
  • * Non-US Resident

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

New York, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0